// App-Quantinova.ai

1674 : Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Researchers

Presenter

  • Alexander Rth

Principal Investigators

  • Wilma Barcellini

  • Shirley D'Sa

  • Yoshitaka Miyakawa

  • Catherine M Broome

  • Marc Michel

  • David J. Kuter

  • Bernd Jilma

  • Tor Henrik Anderson Tvedt

  • Ilene C. Weitz

  • Parija Patel

  • Xiaoyu Jiang

  • Caroline Reuter

  • Jun Su

  • Frank Shafer

  • Michelle Lee

  • William Hobbs

  • Sigbjrn Berentsen

Medical Centers

  • Department of Surgery, University Hospital Essen, Essen, Germany

  • IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milano, Italy

  • UCLH Centre for Waldenström's Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • Thrombosis and Hemostasis Center,Saitama Medical University Hospital,Saitama,Japan

  • Division of Hematology and Oncology, MedStar Georgetown University Hospital, Washington, DC

  • Department of Internal Medicine, National Referral Center for Adult Immune Cytopenias, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France

  • Nephrology Division, Massachusetts General Hospital, Boston, MA

  • Department of Clinical Pharmacology, Medical University of Vienna, Austria

  • Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway

  • Keck School of Medicine of USC, Los Angeles, CA

  • Sanofi, Cambridge, MA

  • Medical Affairs, Sanofi, Cambridge, MA

  • Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Locations

  • Germany

  • Italy

  • United Kingdom

  • Japan

  • United States

  • France

  • Austria

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Multicenteric

Phase

  • III

Study Id's

  • NCT03347396

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved